150 related articles for article (PubMed ID: 16501717)
41. Vaccination against hepatitis B virus infection in neonates.
Pongpipat D; Suvatte V; Assateerawatts A
Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403
[TBL] [Abstract][Full Text] [Related]
42. Barriers and facilitators to hepatitis B birth dose vaccination: Perspectives from healthcare providers and pregnant women accessing antenatal care in Nigeria.
Freeland C; Kanu F; Mohammed Y; Nwokoro UU; Sandhu H; Ikwe H; Uba B; Asekun A; Akataobi C; Adewole A; Fadahunsi R; Wisdom M; Akudo OL; Ugbenyo G; Simple E; Waziri N; Vasumu JJ; Bahuli AU; Bashir SS; Isa A; Ugwu GO; Obi EI; Binta H; Bassey BO; Shuaib F; Bolu O; Tohme RA
PLOS Glob Public Health; 2023; 3(6):e0001332. PubMed ID: 37289735
[TBL] [Abstract][Full Text] [Related]
43. Incremental system costs of introducing combined DTwP-hepatitis B-Hib vaccine into national immunization services in Ethiopia.
Griffiths UK; Korczak VS; Ayalew D; Yigzaw A
Vaccine; 2009 Feb; 27(9):1426-32. PubMed ID: 19146901
[TBL] [Abstract][Full Text] [Related]
44. Update: Shortened Interval for Postvaccination Serologic Testing of Infants Born to Hepatitis B-Infected Mothers.
Schillie S; Murphy TV; Fenlon N; Ko S; Ward JW
MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(39):1118-20. PubMed ID: 26447601
[TBL] [Abstract][Full Text] [Related]
45. [Epidemiological characteristics of children aged 1-4 years without timely birth dose of hepatitis B vaccine vaccination in China, 2014].
Wang FZ; Zhang GM; Shen LP; Liu JH; Zheng H; Wang F; Miao N; Sun XJ; Liang XF; Cui FQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan; 38(1):32-36. PubMed ID: 28100373
[No Abstract] [Full Text] [Related]
46. [Study on the influencing factors of hepatitis B vaccine timely birth dose for infants born at hospitals].
Hu YS; Ding ZR; Huang GF
Zhongguo Yi Miao He Mian Yi; 2009 Oct; 15(5):404-8. PubMed ID: 20084964
[TBL] [Abstract][Full Text] [Related]
47. Telbivudine prevents vertical transmission of hepatitis B virus from women with high viral loads: a prospective long-term study.
Wu Q; Huang H; Sun X; Pan M; He Y; Tan S; Zeng Y; Li L; Deng G; Yan Z; He D; Li J; Wang Y
Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1170-6. PubMed ID: 25251571
[TBL] [Abstract][Full Text] [Related]
48. CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management.
Schillie S; Murphy TV; Sawyer M; Ly K; Hughes E; Jiles R; de Perio MA; Reilly M; Byrd K; Ward JW;
MMWR Recomm Rep; 2013 Dec; 62(RR-10):1-19. PubMed ID: 24352112
[TBL] [Abstract][Full Text] [Related]
49. [Analysis on hepatitis B vaccine coverage among the population of 1-59 years old in Shandong province].
Zhang L; Xu AQ; Yan BY
Zhongguo Yi Miao He Mian Yi; 2009 Apr; 15(2):159-62. PubMed ID: 20077663
[TBL] [Abstract][Full Text] [Related]
50. Hepatitis B Surface Antigen Screening Among Pregnant Women and Care of Infants of Hepatitis B Surface Antigen-Positive Mothers - Guam, 2014.
Abara WE; Cha S; Malik T; DeSimone MS; Schumann B; Mallada E; Klemme M; Aguon V; Santos AM; Collier M; Kamb M
MMWR Morb Mortal Wkly Rep; 2017 May; 66(19):506-508. PubMed ID: 28520708
[TBL] [Abstract][Full Text] [Related]
51. The immunogenicity of GSK's recombinant hepatitis B vaccine in children: a systematic review of 30 years of experience.
van den Ende C; Marano C; van Ahee A; Bunge EM; De Moerlooze L
Expert Rev Vaccines; 2017 Aug; 16(8):789-809. PubMed ID: 28586278
[TBL] [Abstract][Full Text] [Related]
52. Antibody response to postexposure prophylaxis in infants born to hepatitis B surface antigen-positive women.
Euler GL; Copeland JR; Rangel MC; Williams WW
Pediatr Infect Dis J; 2003 Feb; 22(2):123-9. PubMed ID: 12586975
[TBL] [Abstract][Full Text] [Related]
53. [Evaluation on health education of hepatitis B control and prevention in reproductive age women in rural areas].
Xu Y; Liu XZ; Li YD
Zhongguo Yi Miao He Mian Yi; 2009 Jun; 15(3):259-62. PubMed ID: 20084897
[TBL] [Abstract][Full Text] [Related]
54. Maternal characteristics and hospital policies as risk factors for nonreceipt of hepatitis B vaccine in the newborn nursery.
O'Leary ST; Nelson C; Duran J
Pediatr Infect Dis J; 2012 Jan; 31(1):1-4. PubMed ID: 21941215
[TBL] [Abstract][Full Text] [Related]
55. Prevention of Perinatal Transmission of Hepatitis B Virus: Assessment Among Wisconsin Maternity Hospitals.
Borchardt SM; Kocharian A; Hopfensperger D; Davis JP
WMJ; 2016 Apr; 115(2):74-9; quiz 80. PubMed ID: 27197340
[TBL] [Abstract][Full Text] [Related]
56. [Influencing factors of mother-infant vertical transmission of hepatitis B virus].
Zhang WL; Zhao J; Li W
Zhongguo Dang Dai Er Ke Za Zhi; 2011 Aug; 13(8):644-6. PubMed ID: 21849114
[TBL] [Abstract][Full Text] [Related]
57. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.
Xu WM; Cui YT; Wang L; Yang H; Liang ZQ; Li XM; Zhang SL; Qiao FY; Campbell F; Chang CN; Gardner S; Atkins M
J Viral Hepat; 2009 Feb; 16(2):94-103. PubMed ID: 19175878
[TBL] [Abstract][Full Text] [Related]
58. [Assessment of mother-to-child HBV transmission at the prenatal consultation in Vientiane, Laos].
Xaydalasouk K; Keomalaphet S; Latthaphasavang V; Souvong V; Buisson Y
Bull Soc Pathol Exot; 2016 Feb; 109(1):13-9. PubMed ID: 26821371
[TBL] [Abstract][Full Text] [Related]
59. Implementing a Birth Dose of Hepatitis B Vaccine in Africa: Findings from Assessments in 5 Countries.
Moturi E; Tevi-Benissan C; Hagan JE; Shendale S; Mayenga D; Murokora D; Patel M; Hennessey K; Mihigo R
J Immunol Sci; 2018 Aug; Suppl(5):31-40. PubMed ID: 30931434
[TBL] [Abstract][Full Text] [Related]
60. [Efficacy of recombinant hepatitis B vaccine and low-dose hepatitis B immune globulin in preventing mother-infant transmission of hepatitis B virus infection].
Xia GL; Gong J; Wang JJ; Meng ZD; Jia ZY; Cao HL; Liu CB
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 May; 24(5):362-5. PubMed ID: 12820927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
